WO1999047097A3 - Stoffzusammensetzung zur gewebebildung - Google Patents

Stoffzusammensetzung zur gewebebildung Download PDF

Info

Publication number
WO1999047097A3
WO1999047097A3 PCT/DE1999/000781 DE9900781W WO9947097A3 WO 1999047097 A3 WO1999047097 A3 WO 1999047097A3 DE 9900781 W DE9900781 W DE 9900781W WO 9947097 A3 WO9947097 A3 WO 9947097A3
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
material composition
formation
foam
polymerized
Prior art date
Application number
PCT/DE1999/000781
Other languages
English (en)
French (fr)
Other versions
WO1999047097A2 (de
WO1999047097B1 (de
Inventor
Uwe Storch
Original Assignee
Uwe Storch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uwe Storch filed Critical Uwe Storch
Priority to EP99919099A priority Critical patent/EP1064032B1/de
Priority to AT99919099T priority patent/ATE260124T1/de
Publication of WO1999047097A2 publication Critical patent/WO1999047097A2/de
Publication of WO1999047097A3 publication Critical patent/WO1999047097A3/de
Publication of WO1999047097B1 publication Critical patent/WO1999047097B1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • C08G18/12—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/73—Polyisocyanates or polyisothiocyanates acyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/32—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof from compositions containing microballoons, e.g. syntactic foams
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/32—Phosphorus-containing compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2101/00—Manufacture of cellular products
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2230/00—Compositions for preparing biodegradable polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2205/00—Foams characterised by their properties
    • C08J2205/04—Foams characterised by their properties characterised by the foam pores
    • C08J2205/05—Open cells, i.e. more than 50% of the pores are open

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)

Abstract

Eine Stoffzusammensetzung zur Gewebebildung im menschlichen und tierischen Körper polymerisiert als Schaum mit offenen Poren aus, in die das sich bildende Gewebe hineinwächst. Vorzugsweise ist der offenporige Schaum aus aliphatischem Polyurethan polymerisiert und enthält wirkstoffhaltige Hohlkügelchen als Arzniemittelabgabesystem. Die Regeneration von Haut und Nervengewebe verwendet werden.
PCT/DE1999/000781 1998-03-19 1999-03-15 Stoffzusammensetzung zur gewebebildung WO1999047097A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99919099A EP1064032B1 (de) 1998-03-19 1999-03-15 Stoffzusammensetzung zur gewebebildung
AT99919099T ATE260124T1 (de) 1998-03-19 1999-03-15 Stoffzusammensetzung zur gewebebildung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19812195.4 1998-03-19
DE19812195A DE19812195C2 (de) 1998-03-19 1998-03-19 Verfahren zur Herstellung eines gewebebildenden Implantats und seine Verwendung

Publications (3)

Publication Number Publication Date
WO1999047097A2 WO1999047097A2 (de) 1999-09-23
WO1999047097A3 true WO1999047097A3 (de) 1999-11-11
WO1999047097B1 WO1999047097B1 (de) 1999-12-23

Family

ID=7861626

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/000781 WO1999047097A2 (de) 1998-03-19 1999-03-15 Stoffzusammensetzung zur gewebebildung

Country Status (4)

Country Link
EP (1) EP1064032B1 (de)
AT (1) ATE260124T1 (de)
DE (1) DE19812195C2 (de)
WO (1) WO1999047097A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6179840B1 (en) 1999-07-23 2001-01-30 Ethicon, Inc. Graft fixation device and method
US20020095157A1 (en) 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
CA2365376C (en) 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
SE518528C2 (sv) 2000-12-27 2002-10-22 Artimplant Ab Ett förfarande för framställning av ett öppet poröst polymermaterial samt ett öppet poröst polymermaterial
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en) 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US10058642B2 (en) 2004-04-05 2018-08-28 Bluesky Medical Group Incorporated Reduced pressure treatment system
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US8657881B2 (en) 2004-04-20 2014-02-25 Depuy Mitek, Llc Meniscal repair scaffold
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
GB0409446D0 (en) 2004-04-28 2004-06-02 Smith & Nephew Apparatus
EP3360519B1 (de) 2007-11-21 2020-11-18 Smith & Nephew plc Wundauflage
US8808259B2 (en) 2007-11-21 2014-08-19 T.J. Smith & Nephew Limited Suction device and dressing
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
WO2012069794A1 (en) 2010-11-25 2012-05-31 Smith & Nephew Plc Composition i-ii and products and uses thereof
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
EP2886134A1 (de) * 2013-12-20 2015-06-24 nolax AG Resorbierbares Implantat

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
EP0466552A2 (de) * 1990-06-29 1992-01-15 Technion Research & Development Foundation Ltd. Biomedizinische Adhäsivmasse
WO1996010374A1 (en) * 1994-10-03 1996-04-11 Otogen Corporation Differentially biodegradable biomedical implants
US5653996A (en) * 1993-06-30 1997-08-05 Genentech, Inc. Method for preparing liposomes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525731A1 (de) * 1985-07-16 1987-01-22 Wilfried Dr Ing Lemm Verfahren zur herstellung eines nicht toxischen kunststoff-schaum-koerpers
DE3644588C1 (de) * 1986-12-27 1988-03-10 Ethicon Gmbh Implantat und Verfahren zu seiner Herstellung
AU5154390A (en) * 1989-02-15 1990-09-05 Microtek Medical, Inc. Biocompatible material and prosthesis
GB9206509D0 (en) * 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
US5520923A (en) * 1994-09-19 1996-05-28 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
DE19610715C1 (de) * 1996-03-19 1997-06-26 Axel Kirsch Verfahren zum Herstellen eines Knochenersatzmaterials
US5718916A (en) * 1997-02-03 1998-02-17 Scherr; George H. Alginate foam products

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
EP0466552A2 (de) * 1990-06-29 1992-01-15 Technion Research & Development Foundation Ltd. Biomedizinische Adhäsivmasse
US5653996A (en) * 1993-06-30 1997-08-05 Genentech, Inc. Method for preparing liposomes
WO1996010374A1 (en) * 1994-10-03 1996-04-11 Otogen Corporation Differentially biodegradable biomedical implants

Also Published As

Publication number Publication date
EP1064032B1 (de) 2004-02-25
ATE260124T1 (de) 2004-03-15
DE19812195C2 (de) 2000-03-30
WO1999047097A2 (de) 1999-09-23
DE19812195A1 (de) 1999-09-30
EP1064032A2 (de) 2001-01-03
WO1999047097B1 (de) 1999-12-23

Similar Documents

Publication Publication Date Title
WO1999047097A3 (de) Stoffzusammensetzung zur gewebebildung
PH31652A (en) Dihydrolipoic acid as ophthalmological agent to suppress intolerable reactions in the aea between implants and living body tissue.
GB2357969A (en) Improvements in or relating to the treatment of lesions
EP0405556A3 (en) Living hard tissue replacement, its preparation, and preparation of integral body
WO2000038626A3 (en) Substrate composition and method of use for sequestration of skin irritants
CA2283430A1 (en) Elimination of vapour anaesthetics from patients after surgical procedures
EP0790823A4 (de) Arzneistofffreisetzendes chirurgisches implantat bzw. pflastermaterial
HK1018218A1 (en) Tranilast-containing preparation for external application and method of producing the same
GR3036741T3 (en) Biotherapeutic cell-coated microspheres.
DE50014411D1 (de) Medizinisches instrument zur abtragung von gewebe, knochenzement oder dergleichen im menschlichen oder tierischen körper
WO2002007749A3 (en) Device providing regulated growth factor delivery for the regeneration of peripheral nerves
AU3844599A (en) Biostable polyether polyurethane product
WO2001049260A3 (en) Y-ifn liquid-droplet aerosol and method
DE59811657D1 (de) Stent zur implantation im menschlichen körper, insbesondere in blutgefässe
GB9807298D0 (en) Medicament
WO1999010004A3 (en) Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto
WO2002060410A3 (en) Methods for sustained release local delivery of drugs for ablation of unwanted tissue
DE69632967D1 (de) Vorbeugen des graftsabstosses in transplantaten und zur herstellung von universalen gentherapie wirtszell, unter anwendung von lymphozytenaktivierungsgen-3 (lag-3)
CA2222698A1 (fr) Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
AU4262599A (en) Preparation for treating human skin and human hair comprising a special active ingredient combination, and the use of this active ingredient combination
EP0276836A3 (de) Implantierbares Material und Verfahren zu seiner Herstellung
PL330597A1 (en) Transcutaneous systems containing two active ingredients in separate compartments, method of obtaining them and their application as therapeutic agents
WO1998024898A3 (en) Therapeutic composition comprising the kal protein and use of the kal protein
EP0373771A3 (de) Neue pharmazeutische Anwendungen von Cystatinen
CA2091134A1 (en) Therapeutic agent for threatened abortion

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: B1

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999919099

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09646425

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999919099

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1999919099

Country of ref document: EP